Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

Thakore, Pratiksha I, D'Ippolito, Anthony M, Song, Lingyun, Safi, Alexias, Shivakumar, Nishkala K, Kabadi, Ami M, Reddy, Timothy E, Crawford, Gregory E +1 more·2015·Nature Methods

Cited by (1,000)

Items 501–600 of 1,000

  1. JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
    Chuanjie Zhang, Jiawei Ding, Kiat Shenq Lim, Wenjie Zhou, Wenyu Miao, Siqi Wu, Hanqing Liu, Da Huang, Chufeng Chen, Hongchao He et al. · 2025 · Cancer Research
  2. Toward the Treatment of Inherited Diseases of the Retina Using CRISPR-Based Gene Editing
    Jennifer Hernández-Juárez, Genaro Rodríguez‐Uribe, Shyamanga Borooah · 2021 · Frontiers in Medicine
  3. A Review on CRISPR-mediated Epigenome Editing: A Future Directive for Therapeutic Management of Cancer
    Dipanjan Ghosh, Rudra Chakravarti, Swadhin Kumar Lenka, Anupam Gautam, Rajveer Singh, V. Ravichandiran, Syamal Roy · 2022 · Current Drug Targets
  4. Cellular Genome-wide Association Study Identifies Common Genetic Variation Influencing Lithium-Induced Neural Progenitor Proliferation
    Justin M. Wolter, Brandon D. Le, Nana Matoba, Michael J. Lafferty, Nil Aygün, Dan Liang, Kenan P. Courtney, Juan Song, Joseph Piven, Mark J. Zylka et al. · 2022 · Biological Psychiatry
  5. Regulation of KDM5C stability and enhancer reprogramming in breast cancer
    Qiong Xiao, Chenyu Wang, Chuan Gao, Jidong Chen, Jingjing Chen, Zhen Wang, Lingao Ju, Shan‐Bo Tang, Jie Yao, Li Feng et al. · 2022 · Cell Death and Disease
  6. Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas
    Fei Teng, Meng Guo, Fang Liu, Ce Wang, Jiayong Dong, Lei Zhang, You Zou, Rui Chen, Ke-Yan Sun, Hong Yu Fu et al. · 2016 · Oncotarget
  7. Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma
    Etsuko Yokota, Tomoki Yamatsuji, Munenori Takaoka, Minoru Haisa, Nagio Takigawa, Noriko Miyake, Tomoko Ikeda, Tomoaki Mori, Serika Ohno, Takashi Sera et al. · 2017 · Oncotarget
  8. The physicist’s guide to one of biotechnology’s hottest new topics: CRISPR-Cas
    Melia E. Bonomo, Michael W Deem · 2018 · Physical Biology
  9. CRISPR-based methods for high-throughput annotation of regulatory DNA
    Tyler S. Klann, Joshua B. Black, Charles A. Gersbach · 2018 · Current Opinion in Biotechnology
  10. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing
    Kyung Hyun Yoo, Lothar G. Hennighausen, Ha Youn Shin · 2018 · Journal of Mammary Gland Biology and Neoplasia
  11. Netrin G1 promotes pancreatic tumorigenesis through cancer associated fibroblast driven nutritional support and immunosuppression
    Ralph Francescone, Debora Barbosa Vendramini Costa, Janusz Franco-Barraza, Jessica Wagner, Alexander Muir, Allison N. Lau, Linara Gabitova, Tatiana Pazina, Sapna Gupta, Tiffany Luong et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Inhibition of human-HPV hybrid ecDNA enhancers reduces oncogene expression and tumor growth in oropharyngeal cancer
    Takuya Nakagawa, Jens Luebeck, Kaiyuan Zhu, Joshua T. Lange, Roman Šášik, Chad Phillips, Sayed Sadat, Sara Javadzadeh, Qian Yang, Abdula Monther et al. · 2025 · Nature Communications
  13. Dissecting gene regulatory networks governing human cortical cell fate
    Jingwen W Ding, Chang N. Kim, Megan S Ostrowski, Yashodara Abeykoon, Bryan J. Pavlovic, Jenelle L. Wallace, Nathan K. Schaefer, Tomasz Jan Nowakowski, Alex A. Pollen · 2026 · Nature
  14. Engineering of the Epigenome: Synthetic Biology to Define Functional Causality and Develop Innovative Therapies
    Jörg Tost · 2016 · Epigenomics
  15. Recent advances and current status of gene therapy for epilepsy
    Aojie Cai, Kai Gao, Fan Zhang, Yuwu Jiang · 2024 · World Journal of Pediatrics
  16. CRISPR-based tools for plant genome engineering
    Nathalia Volpi e Silva, Nicola J. Patron · 2017 · Emerging Topics in Life Sciences
  17. Rapid and Simple Screening of CRISPR Guide RNAs (gRNAs) in Cultured Cells Using Adeno-Associated Viral (AAV) Vectors
    Julia Fakhiri, Manuela Nickl, Dirk Grimm · 2019 · Methods in molecular biology
  18. Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells
    Bing Liu, Jingyuan Song, Haote Han, Zhengping Hu, Na Chen, Jing Z Cui, Joanne Aiko Matsubara, Jingxiang Zhong, Hetian Lei · 2019 · Laboratory Investigation
  19. CRISPRi-mediated functional analysis of lung disease-associated loci at non-coding regions
    William D. Stuart, Minzhe Guo, Iris M. Fink-Baldauf, Alan M. Coleman, John Paul Clancy, Marcus Alexander Mall, Foong‐Yen Y. Lim, John J. Brewington, Yutaka Maeda · 2020 · NAR Genomics and Bioinformatics
  20. CRISPR/Cas9 in epigenetics studies of health and disease
    Pranati Sar, Sarat Kumar Dalai · 2021 · Progress in molecular biology and translational science
  21. Recent advances in CRISPR technologies for genome editing
    Myeonghoon Song, Taeyoung Koo · 2021 · Archives of Pharmacal Research
  22. Perfecting Targeting in CRISPR
    Hainan Zhang, Tong Li, Yidi Sun, Hui Yang · 2021 · Annual Review of Genetics
  23. Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer
    Demetra P. Kelenis, Kathia E. Rodarte, Rahul Krishna Kollipara, Karine Pozo, Shreoshi Pal Choudhuri, Kyle B. Spainhower, Sarah J. Wait, Victor Stastny, Trudy G. Oliver, Jane E. B. Johnson · 2022 · Cancer Research
  24. Precision gene editing: The power of CRISPR-Cas in modern genetics
    Jeong H. Joo, Soogene Lee, Keun Pil Kim · 2025 · Molecular Therapy — Nucleic Acids
  25. OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
    Mila Gugnoni, Gloria Manzotti, Emanuele Vitale, Elisabetta Sauta, Federica Torricelli, Francesca Reggiani, Mariaelena Pistoni, Simonetta Piana, Alessia Ciarrocchi · 2022 · Journal of Experimental & Clinical Cancer Research
  26. Application of CRISPR-Mediated Gene Editing for Crop Improvement
    Chandranandani Negi, Neeraj Kumar Vasistha, Dharmendra Singh, Pritesh Vyas, Harcharan Singh Dhaliwal · 2022 · Molecular Biotechnology
  27. CRISPR/Cas9-mediated epigenetic editing tool: An optimized strategy for targeting de novo DNA methylation with stable status via homology directed repair pathway
    Jie Wang, Dandan Li, Jing Yang, Chang Lu, Rui Zhang, Jinming Li · 2022 · Biochimie
  28. FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung
    Koichi Tomoshige, William D. Stuart, Iris M. Fink-Baldauf, Masaoki Ito, Tomoshi Tsuchiya, Takeshi Nagayasu, Tomoki Yamatsuji, Morihito Okada, Takuya Fukazawa, Minzhe Guo et al. · 2023 · Cancer Research
  29. Emerging Gene-editing nano-therapeutics for Cancer
    Najma Nujoom, Manzoor Koyakutty, Lalitha Biswas, Thangarajan Rajkumar, Shantikumar Vasudevan Nair · 2024 · Heliyon
  30. Chromosomal Conformations and Epigenomic Regulation in Schizophrenia
    Prashanth Rajarajan, Yan ping Jiang, Bibi S. Kassim, Schahram Akbarian · 2018 · Progress in molecular biology and translational science
  31. Valproic Acid Significantly Improves CRISPR/Cas9-Mediated Gene Editing
    Hanseul Park, Jaein Shin, Hwan Geun Choi, Byounggook Cho, Jongpil Kim · 2020 · Cells
  32. Regenerating Urethral Striated Muscle by CRISPRi/dCas9-KRAB-Mediated Myostatin Silencing for Obesity-Associated Stress Urinary Incontinence
    Huixing Yuan, Yajun Ruan, Yan Lin Tan, Amanda B. Reed‐Maldonado, Yinwei Chen, Dehua Zhao, Zhao Wang, Feng Zhou, Dongyi Peng, Lia Banie et al. · 2020 · The CRISPR Journal
  33. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis
    Ami M. Kabadi, Leah Machlin, Nikita Dalal, Rhianna E. Lee, Ian C. McDowell, Nirav N. Shah, Lauren Drowley, Scott H. Randell, Timothy E. Reddy · 2021 · Journal of Cystic Fibrosis
  34. CRISPR-Based Genetic Switches and Other Complex Circuits: Research and Application
    Pei Du, Chunbo Lou, Xuejin Zhao, Qihui Wang, Xiangyu Ji, Weijia Wei · 2021 · Life
  35. Systematic identification of genomic elements that regulate FCGR2A expression and harbor variants linked with autoimmune disease
    Johanna Dahlqvist, Charles P. Fulco, John P Ray, Thomas Liechti, Carl G. de Boer, David Lieb, Thomas Eisenhaure, J Engreitz, Mario Roederer, Nir Hacohen · 2021 · Human Molecular Genetics
  36. Identifying an oligodendrocyte enhancer that regulatesOlig2expression
    Chuandong Fan, Dongkyeong Kim, Hongjoo An, Yungki Park · 2022 · Human Molecular Genetics
  37. Enhancers: A Focus on Synthetic Biology and Correlated Gene Expression
    Christopher H. Bohrer, Nadezda A. Fursova, Daniel R. Larson · 2024 · ACS Synthetic Biology
  38. Advancements in gene therapies targeting mutant KRAS in cancers
    Yuhang Wang, Thuy Anh Bui, Xinpu Yang, György Hutvágner, Wei Deng · 2025 · Cancer and Metastasis Reviews
  39. Three-dimensional analysis of single molecule FISH in human colon organoids
    Manja Omerzu, Nicola Fenderico, Buys de Barbanson, Joep Sprangers, Jeroen de Ridder, Madelon M. Maurice · 2019 · Biology Open
  40. Comprehensive Mapping of Key Regulatory Networks that Drive Oncogene Expression
    Lin Lin, Benjamin R. Holmes, Max W. Shen, Darnell Kammeron, Niels Geijsen, David Kenneth Gifford, Richard I. Sherwood · 2020 · Cell Reports
  41. Using Stem Cell Models to Explore the Genetics Underlying Psychiatric Disorders: Linking Risk Variants, Genes, and Biology in Brain Disease
    Kristen Brennand · 2022 · American Journal of Psychiatry
  42. Decoding polygenic diseases: advances in noncoding variant prioritization and validation
    Iris M. Chin, Zachary A. Gardell, M. Ryan Corces · 2024 · Trends in Cell Biology
  43. Identification of rheumatoid arthritis causal genes using functional genomics
    James Ding, Gisela Orozco · 2019 · Scandinavian Journal of Immunology
  44. CHD-associated enhancers shape human cardiomyocyte lineage commitment
    Daniel A. Armendariz, Sean C. Goetsch, Anjana Sundarrajan, Sushama Sivakumar, Yihan Wang, Shiqi Xie, Nikhil Munshi, Gary C. Hon · 2023 · eLife
  45. Cooperation between IRTKS and deubiquitinase OTUD4 enhances the SETDB1-mediated H3K9 trimethylation that promotes tumor metastasis via suppressing E-cadherin expression
    Xiaofang Cui, Xueying Shang, Jia Xie, Chen-Yi Xie, Zhanyun Tang, Qing Luo, Chong-Chao Wu, Guangxing Wang, Na Wang, Kunyan He et al. · 2023 · Cancer Letters
  46. Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
    Xiang Lin, Jidong Chen, Chen-Yu Wang, Zhen Cai, Rui Zhan, Yang Chen, La-Ying Zhang, Lianyun Li, Yong Xiao, Mingkai Chen et al. · 2023 · Genome biology
  47. Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems
    Amalie Dyrelund Broksø, Louise Bendixen, Simon Fammé, Kasper Mikkelsen, Trine I. Jensen, Rasmus Otkjær Bak · 2024 · Molecular Therapy
  48. Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential
    Md Sadique Hussain, Somya Sharma, Alka Kumari, Almaz Kamran, Gurusha Bahl, Ajay Singh Bisht, Ayesha Sultana, Sumel Ashique, Prasanna Srinivasan Ramalingam, Sivakumar Arumugam · 2024 · Epigenomics
  49. Role of long non-coding RNAs in lymphoma: A systematic review and clinical perspectives
    Juan Yang, Xin Wang · 2019 · Critical Reviews in Oncology/Hematology
  50. A CRISPR view of hematopoietic stem cells: Moving innovative bioengineering into the clinic
    Atesh K. Worthington, E. Camilla Forsberg · 2022 · American Journal of Hematology
  51. Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport
    Yajuan Shi, Hyosung Kim, Catherine A. Hamann, Elizabeth M. Rhea, Jonathan M. Brunger, Ethan S. Lippmann · 2022 · Fluids and Barriers of the CNS
  52. Applications of genome editing by programmable nucleases to the metabolic engineering of secondary metabolites
    Ana Lúcia Leitão, Marina C. Costa, Francisco J. Enguita · 2016 · Journal of Biotechnology
  53. CRISPR-engineered genome editing for the next generation neurological disease modeling
    Weijun Feng, Hai‐Kun Liu, Daisuke Kawauchi · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  54. The epigenomics of schizophrenia, in the mouse
    Behnam Javidfar, Royce Park, Bibi S. Kassim, Lucy K. Bicks, Schahram Akbarian · 2017 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  55. Generating tissue-resident macrophages from pluripotent stem cells: Lessons learned from microglia
    Christel Claes, Johanna Van Den Daele, Catherine M. Verfaillie · 2018 · Cellular Immunology
  56. Efficient and Orthogonal Transcription Regulation by Chemically Inducible Artificial Transcription Factors
    Wataru Nomura, Daisuke Matsumoto, Taisuke Sugii, Takuya Kobayakawa, Hirokazu Tamamura · 2018 · Biochemistry
  57. Tailored chromatin modulation to promote tissue regeneration
    Paloma Martínez‐Redondo, Juan Carlos Izpisúa Belmonte · 2019 · Seminars in Cell and Developmental Biology
  58. Genome-wide annotation of gene regulatory elements linked to cell fitness
    Maria ter Weele, Tyler S. Klann, Alejandro Barrera, Adarsh R. Ettyreddy, Siyan Liu, Ryan A. Rickels, Julien Bryois, Simon W. Jiang, Shaunak Sanjay Adkar, Nahid Iglesias et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  59. PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system
    Jounghyun H. Lee, Kevin L. Shores, Jason J. Breithaupt, Caleb S. Lee, Daniella M. Fodera, Jennifer B. Kwon, Adarsh R. Ettyreddy, Kristin M. Myers, Benny J. Evison, Alexandra K. Suchowerska et al. · 2023 · APL Bioengineering
  60. Modulation of SLFN11 induces changes in DNA Damage response in breast cancer
    Christophe Michel Raynaud, Eiman I. Ahmed, Ayesha Jabeen, Apryl Sanchez, Shimaa Sherif, Tatiana Carneiro-Lobo, Amany S. Awad, Dina Awartani, Adviti Naik, Remy Thomas et al. · 2023 · Cancer Cell International
  61. Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci
    Kaiyu Jiang, Haeja A. Kessler, Yungki Park, Marc Sudman, Susan D. Thompson, James N. Jarvis · 2020 · PLoS ONE
  62. Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing
    Sarah Balderston, Gabrielle Clouse, Juan José Ripoll, Grace K. Pratt, Giedrius Gasiūnas, Jens-Ole Bock, Eric Bennett, Kiana Aran · 2021 · The CRISPR Journal
  63. Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer?
    Carol Imbriano, Silvia Belluti · 2022 · International Journal of Molecular Sciences
  64. Decoding transcriptional enhancers: Evolving from annotation to functional interpretation
    Krysta L. Engel, Mark Mackiewicz, Andrew A. Hardigan, R Myers, Daniel Savic · 2016 · Seminars in Cell and Developmental Biology
  65. Recent developments in genome editing for potential use in plants
    Jonathan Townson · 2017 · Bioscience Horizons The International Journal of Student Research
  66. Decision-Making in Cascade Complexes Harboring crRNAs of Altered Length
    Inga Songailienė, Marius Rutkauskas, Tomas Šinkūnas, E. Manakova, Sabine Wittig, Carla Schmidt, Virginijus Šikšnys, Ralf Seidel · 2019 · Cell Reports
  67. Sufficiency analysis of estrogen responsive enhancers using synthetic activators
    Matthew Ginley-Hidinger, Julia B. Carleton, Adriana Cristina Rodriguez, Kristofer C. Berrett, Jason Gertz · 2019 · Life Science Alliance
  68. Re-purposing Ac/Ds transgenic system for CRISPR/dCas9 modulation of enhancers and non-coding RNAs in zebrafish
    Vanessa Chong-Morrison, Filipa Costa Simões, Upeka Senanayake, Dervla S. Carroll, Paul Richard Riley, Tatjana Sauka‐Spengler · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Epigenetic mechanisms regulating plant responses to abiotic stress and their role in developing climate resilient crops
    J. Bevin Nishanth, Baburao Gaddala, Suji Somasundaram, P. Rifa Fathima, A. Premkumar, Balasankar Karavadi, R S A Sorna Kumar, Jeyaraj Iyyappan, Yuvaraj Dinakarkumar · 2025 · Discover Plants.
  70. The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma
    Nan Qin, Eunice Paisana, Daniel J. Picard, Gabriel Leprivier, Maike Langini, Carlos Custódia, Rita Cascão, Catleen Conrad, Mirko Peitzsch, Anja Stefanski et al. · 2023 · Journal of Neuro-Oncology
  71. Chem-CRISPR/dCas9FCPF: a platform for chemically induced epigenome editing
    Mukaddes Altinbay, Jianhui Wang, Jie Chen, Daniel Schäfer, Maximilian Sprang, Biljana Blagojevic, Stefan Wölfl, Miguel Angel Andrade-Navarro, Ivan Đikić, Stefan Knapp et al. · 2024 · Nucleic Acids Research
  72. Targeted CRISPR regulation of ZNF865 enhances stem cell cartilage deposition, tissue maturation rates, and mechanical properties in engineered intervertebral discs
    Hunter Levis, Christian J. Lewis, Matthew Fainor, Ameerah Lawal, Elise Stockham, Jacob D. Weston, Niloofar Farhang, Sarah E. Gullbrand, Robby D. Bowles · 2024 · Acta Biomaterialia
  73. Characterization of diverse Cas9 orthologs for genome and epigenome editing
    Gabriel L. Butterfield, Dahlia Rohm, Avery Roberts, Matthew A. Nethery, Anthony J. Rizzo, Daniel J. Morone, Lisa Garnier, Nahid Iglesias, Rodolphe Barrangou, Charles A. Gersbach · 2025 · Proceedings of the National Academy of Sciences
  74. CRISPR-enabled genetic logic circuits for biosensing
    Xiyan Wang, Yuanli Gao, Nan Zhou, Zhugen Yang, Jonathan M. Cooper, Baojun Wang · 2025 · TrAC Trends in Analytical Chemistry
  75. Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential
    Fan Wu, Wuhui He, Yun Xiao, Qiong Wu, Qing Zhang, Tiesong Zhang, Lei Xu, Xinyi Pang · 2025 · Advanced Science
  76. Expanding horizons of CRISPR applications beyond genome editing
    Yu Liang, Shengkun Tong, Jingyu Zhang, Gao‐Yi Tan, Lixin Zhang, Sang Yup Lee, Yaojun Tong · 2025 · Trends in Genetics
  77. CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases
    Desh Deepak Singh, R. David Hawkins, Riitta Lahesmaa, Subhash Kumar Tripathi · 2019 · Seminars in Cell and Developmental Biology
  78. Epigenetic Editing in Prostate Cancer: Challenges and Opportunities
    Mariana Brütt Pacheco, Vânia Camilo, Rui Henrique, Cármen Jerónimo · 2021 · Epigenetics
  79. Excitatory Amino Acid Transporter 1 Supports Adult Hippocampal Neural Stem Cell Self-Renewal
    Joshua D. Rieskamp, Ileanexis Rosado-Burgos, Jacob E. Christofi, Eliza Ansar, Dalia Einstein, Ashley E. Walters, Valentina Valentini, John P. Bruno, Elizabeth D. Kirby · 2022 · iScience
  80. Plant Tissue Culture: A Battle Horse in the Genome Editing Using CRISPR/Cas9
    Victor Manuel Loyola-Vargas, Randy N. Avilez-Montalvo · 2018 · Methods in molecular biology
  81. An Agrobacterium-Mediated CRISPR/Cas9 Platform for Genome Editing in Maize
    Keunsub Lee, Huilan Zhu, Bing Yang, Kan Wang · 2019 · Methods in molecular biology
  82. An introduction to genome editing CRISPR-Cas systems
    Vijai Singh · 2020 · Elsevier eBooks
  83. Nonsense‐mediated decay factor SMG7 sensitizes cells to TNFα‐induced apoptosis via CYLD tumor suppressor and the noncoding oncogene Pvt1
    Limeng Yang, Vanessa A. N. Kraft, Susanne Pfeiffer, Juliane Merl‐Pham, Xuanwen Bao, Yu An, Stefanie M. Hauck, Joel Schick · 2020 · Molecular Oncology
  84. Discovering functional sequences with RELICS, an analysis method for CRISPR screens
    Patrick C. Fiaux, Hsiuyi V. Chen, Poshen B. Chen, Aaron R. Chen, Graham McVicker · 2020 · PLoS Computational Biology
  85. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
    Shaina N. Porter, Rachel M. Levine, Shondra M. Pruett‐Miller · 2019 · Comprehensive physiology
  86. Gene regulatory activity associated with polycystic ovary syndrome revealed DENND1A-dependent testosterone production
    Laavanya Sankaranarayanan, Kelly Brewer, Shauna Morrow, Graham D. Johnson, Alejandro Barrera, Revathy Venukuttan, Ryan K. Sisk, Andrea Elizabeth Dunaif, Timothy E. Reddy · 2025 · Nature Communications
  87. Non-coding RNA LEVER sequestration of PRC2 can mediate long range gene regulation
    Wei Wen Teo, Xinang Cao, Chan-Shuo Wu, Hong Kee Tan, Qiling Zhou, Chong Gao, Kim Vanuytsel, Sara S. Kumar, George J. Murphy, Henry He Yang et al. · 2022 · Communications Biology
  88. Repression of HIV-1 reactivation mediated by CRISPR/dCas9-KRAB in lymphoid and myeloid cell models
    Lendel Correia da Costa, Larissa Bomfim, Uilla Victoria Torres Dittz, Camila de Almeida Velozo, Rodrigo Delvecchio da Cunha, Amílcar Tanuri · 2022 · Retrovirology
  89. Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2
    Laura Schmitt, Ilka Lechtenberg, Daniel Drießen, Hector Flores‐Romero, Margaretha A. Skowron, Marlena Sekeres, Julia Hoppe, Karina Stephanie Krings, Tanya R. Llewellyn, Christoph Peter et al. · 2024 · Cell Death Discovery
  90. Unlocking biological mechanisms with integrative functional genomics approaches
    Sehee Yun, Minsoo Noh, Jivin Yu, Hyeon-Jai Kim, Chi‐chung Hui, Hunsang Lee, Joe Eun Son · 2024 · Molecules and Cells
  91. Genetically encoded fluorescent reporter for polyamines
    Pushkal Sharma, Colin Y. Kim, Heather R. Keys, Shinya Imada, Alex B. Joseph, Luke S. Ferro, Tenzin Kunchok, Rachel Anderson, Yulin Sun, Ömer H. Yilmaz et al. · 2025 · Nature Communications
  92. Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management
    Chan Young Kang, Kyung Wook Been, Mi Ra Kang, Myung Su Choi, Rae Hee Kang, Junseok W. Hur, Junho K. Hur · 2025 · Neurospine
  93. Epigenome rewiring in human pluripotent stem cells
    Jielin Yan, D. Huangfu · 2021 · Trends in Cell Biology
  94. Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)
    Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, Raquel Blanco Martínez-Illescas, Ángela Pastor Senovilla, Marian Lozano Yagüe, Alfonsina Trento, Rosa García-Martín, Diego Navarro, Bruno Sáinz et al. · 2022 · Cancers
  95. LncMIR181A1HG is a novel chromatin-bound epigenetic suppressor of early stage osteogenic lineage commitment
    Coralee E. Tye, Prachi N. Ghule, Jonathan A. R. Gordon, Fleur S. Kabala, Natalie A. Page, Michelle M. Falcone, Kirsten M. Tracy, André J. van Wijnen, Janet Lee Stein, Jane B. Lian et al. · 2022 · Scientific Reports
  96. Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancer
    Daham Kim, Juyeon Yu, Jiwon Kim, Yoon-a Hwang, Jin Kyong Kim, Cheol Ryong Ku, Jung Hyun Yoon, Jin Young Kwak, Kee‐Hyun Nam, Eun Jig Lee · 2022 · Frontiers in Oncology
  97. Haplotype-specific chromatin looping reveals genetic interactions of regulatory regions modulating gene expression in 8p23.1
    Mariana Saint Just Ribeiro, Pulak Tripathi, Bahram Namjou, John B. Harley, Iouri Chepelev · 2022 · Frontiers in Genetics
  98. Integration of 3D genome topology and local chromatin features uncovers enhancers underlying craniofacial-specific cartilage defects
    Qiming Chen, Jiewen Dai, Qian Bian · 2022 · Science Advances
  99. Hnrnpk is essential for embryonic limb bud development as a transcription activator and a collaborator of insulator protein Ctcf
    Yuyu Chen, Taifeng Zhou, Zhiheng Liao, Wenjie Gao, Jinna Wu, Shun Zhang, Yongyong Li, Hengyu Liu, Hang Zhou, Caixia Xu et al. · 2023 · Cell Death and Differentiation
  100. Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression
    Ryo Shiraishi, Gabriele Cancila, Kohei Kumegawa, Jacob Torrejon-Diaz, Irene Basili, Flavia Bernardi, Patricia Benites Goncalves da Silva, Wan-Chen Wang, Owen S. Chapman, Liying Yang et al. · 2024 · Developmental Cell